However, the increased frequency of FcγRIIB+CD8+ T cells at the tumor coupled with the increased secretion of Fgl2 by CD11b+ cells at the tumor further amplifies this negative feedback loop, resulting in a curtailed T cell antitumor response. This evidence concerns the gene FGL2 and neoplasm.